Big Food Tries to Limit GLP-1 Hit With Vitamins, Meals
- Yogurt flies off shelves as GLP-1 users seek healthier snacks
- Nestle launches new website with custom vitamins, supplements
This article is for subscribers only.
The so-called Ozempic Revolution has wiped billions off the market value of food and drink companies. But new weight-loss drugs are boosting at least one line of products that has sometimes faced sluggish demand: yogurt.
France’s Danone says it’s seeing a jump in demand for its high-protein, low calorie yogurts in the US that it attributes partly to the new obesity-treatment craze. US regulators also have helped by endorsing the product, saying two cups a week could reduce the risk of diabetes.